Baidu
map

J Sports Med Phys Fitness:简化太极运动可缓解轻度至中度帕金森病患者的症状

2020-08-03 MedSci原创 MedSci原创

太极是一种体育锻炼,可以作为一种非药物方法来减轻帕金森病的症状。本研究旨在探讨与单纯的常规运动方案对比,简化的太极训练加常规运动对轻中度帕金森病患者运动和非运动症状的影响。

太极是一种体育锻炼,可以作为一种非药物方法来减轻帕金森病的症状。本研究旨在探讨与单纯的常规运动方案对比,简化的太极训练加常规运动对轻中度帕金森病患者运动和非运动症状的影响。

将41名帕金森病门诊患者和住院患者随机分为太极组(N.=19)和常规锻炼组 (对照组,N.=22),为期12周。太极组包括太极拳训练和日常锻炼。评估运动和非运动功能。通过统一帕金森氏疾病评分量表第III部分(UPDRS-III)和伯格平衡量表(BBS)评估运动功能。帕金森病问卷-39(PDQ-39)、帕金森病睡眠量表(PDSS)、汉密尔顿抑郁量表(HAMD)、汉密尔顿焦虑量表(HAMA)、蒙特利尔认知评估(MOCA)分别评估非运动症状如生活质量、睡眠质量、抑郁和焦虑状态、认知功能。

结果显示,经过12周的干预,太极组和常规运动组的参与者在UPDRS-III、BBS、PDQ-39、PDSS和HAMD方面都较基线获得了改善。然而,太极组和常规运动组仅在PDSS(P=0.029)和MoCA(P=0.024)上有明显改善。

因此,太极训练联合常规运动可能是一种理想的非药物治疗PD患者运动和非运动症状的替代方法,尤其是对帕金森病患者睡眠质量和认知功能的改善比单纯的常规运动方案更有帮助。

原始出处:

Mingjin ZhuYonghua Zhang, et al., Effect of simplified Tai Chi exercise on relieving symptoms of patients with mild to moderate Parkinson's disease. J Sports Med Phys Fitness. 2020 Feb;60(2):282-288. doi: 10.23736/S0022-4707.19.10104-1. 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1757424, encodeId=2df41e5742415, content=<a href='/topic/show?id=058e4852e63' target=_blank style='color:#2F92EE;'>#帕金森病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48527, encryptionId=058e4852e63, topicName=帕金森病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a17f37322741, createdName=ms6832696159214430, createdTime=Sun Aug 23 15:57:53 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632133, encodeId=4825163213332, content=<a href='/topic/show?id=34c74421593' target=_blank style='color:#2F92EE;'>#太极#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44215, encryptionId=34c74421593, topicName=太极)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec5221859655, createdName=steven_u9, createdTime=Wed Nov 04 18:57:53 CST 2020, time=2020-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1331959, encodeId=008f1331959d6, content=<a href='/topic/show?id=eac1e47058' target=_blank style='color:#2F92EE;'>#FIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7470, encryptionId=eac1e47058, topicName=FIT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Wed Aug 05 12:57:53 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573937, encodeId=0ce715e39377d, content=<a href='/topic/show?id=6b3348526a0' target=_blank style='color:#2F92EE;'>#帕金森病患#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48526, encryptionId=6b3348526a0, topicName=帕金森病患)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73fe15977481, createdName=saikp, createdTime=Wed Aug 05 12:57:53 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610625, encodeId=ed481610625ad, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Aug 05 12:57:53 CST 2020, time=2020-08-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1757424, encodeId=2df41e5742415, content=<a href='/topic/show?id=058e4852e63' target=_blank style='color:#2F92EE;'>#帕金森病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48527, encryptionId=058e4852e63, topicName=帕金森病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a17f37322741, createdName=ms6832696159214430, createdTime=Sun Aug 23 15:57:53 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632133, encodeId=4825163213332, content=<a href='/topic/show?id=34c74421593' target=_blank style='color:#2F92EE;'>#太极#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44215, encryptionId=34c74421593, topicName=太极)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec5221859655, createdName=steven_u9, createdTime=Wed Nov 04 18:57:53 CST 2020, time=2020-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1331959, encodeId=008f1331959d6, content=<a href='/topic/show?id=eac1e47058' target=_blank style='color:#2F92EE;'>#FIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7470, encryptionId=eac1e47058, topicName=FIT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Wed Aug 05 12:57:53 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573937, encodeId=0ce715e39377d, content=<a href='/topic/show?id=6b3348526a0' target=_blank style='color:#2F92EE;'>#帕金森病患#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48526, encryptionId=6b3348526a0, topicName=帕金森病患)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73fe15977481, createdName=saikp, createdTime=Wed Aug 05 12:57:53 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610625, encodeId=ed481610625ad, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Aug 05 12:57:53 CST 2020, time=2020-08-05, status=1, ipAttribution=)]
    2020-11-04 steven_u9
  3. [GetPortalCommentsPageByObjectIdResponse(id=1757424, encodeId=2df41e5742415, content=<a href='/topic/show?id=058e4852e63' target=_blank style='color:#2F92EE;'>#帕金森病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48527, encryptionId=058e4852e63, topicName=帕金森病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a17f37322741, createdName=ms6832696159214430, createdTime=Sun Aug 23 15:57:53 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632133, encodeId=4825163213332, content=<a href='/topic/show?id=34c74421593' target=_blank style='color:#2F92EE;'>#太极#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44215, encryptionId=34c74421593, topicName=太极)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec5221859655, createdName=steven_u9, createdTime=Wed Nov 04 18:57:53 CST 2020, time=2020-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1331959, encodeId=008f1331959d6, content=<a href='/topic/show?id=eac1e47058' target=_blank style='color:#2F92EE;'>#FIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7470, encryptionId=eac1e47058, topicName=FIT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Wed Aug 05 12:57:53 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573937, encodeId=0ce715e39377d, content=<a href='/topic/show?id=6b3348526a0' target=_blank style='color:#2F92EE;'>#帕金森病患#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48526, encryptionId=6b3348526a0, topicName=帕金森病患)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73fe15977481, createdName=saikp, createdTime=Wed Aug 05 12:57:53 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610625, encodeId=ed481610625ad, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Aug 05 12:57:53 CST 2020, time=2020-08-05, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1757424, encodeId=2df41e5742415, content=<a href='/topic/show?id=058e4852e63' target=_blank style='color:#2F92EE;'>#帕金森病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48527, encryptionId=058e4852e63, topicName=帕金森病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a17f37322741, createdName=ms6832696159214430, createdTime=Sun Aug 23 15:57:53 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632133, encodeId=4825163213332, content=<a href='/topic/show?id=34c74421593' target=_blank style='color:#2F92EE;'>#太极#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44215, encryptionId=34c74421593, topicName=太极)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec5221859655, createdName=steven_u9, createdTime=Wed Nov 04 18:57:53 CST 2020, time=2020-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1331959, encodeId=008f1331959d6, content=<a href='/topic/show?id=eac1e47058' target=_blank style='color:#2F92EE;'>#FIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7470, encryptionId=eac1e47058, topicName=FIT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Wed Aug 05 12:57:53 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573937, encodeId=0ce715e39377d, content=<a href='/topic/show?id=6b3348526a0' target=_blank style='color:#2F92EE;'>#帕金森病患#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48526, encryptionId=6b3348526a0, topicName=帕金森病患)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73fe15977481, createdName=saikp, createdTime=Wed Aug 05 12:57:53 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610625, encodeId=ed481610625ad, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Aug 05 12:57:53 CST 2020, time=2020-08-05, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1757424, encodeId=2df41e5742415, content=<a href='/topic/show?id=058e4852e63' target=_blank style='color:#2F92EE;'>#帕金森病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48527, encryptionId=058e4852e63, topicName=帕金森病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a17f37322741, createdName=ms6832696159214430, createdTime=Sun Aug 23 15:57:53 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632133, encodeId=4825163213332, content=<a href='/topic/show?id=34c74421593' target=_blank style='color:#2F92EE;'>#太极#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44215, encryptionId=34c74421593, topicName=太极)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec5221859655, createdName=steven_u9, createdTime=Wed Nov 04 18:57:53 CST 2020, time=2020-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1331959, encodeId=008f1331959d6, content=<a href='/topic/show?id=eac1e47058' target=_blank style='color:#2F92EE;'>#FIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7470, encryptionId=eac1e47058, topicName=FIT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Wed Aug 05 12:57:53 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573937, encodeId=0ce715e39377d, content=<a href='/topic/show?id=6b3348526a0' target=_blank style='color:#2F92EE;'>#帕金森病患#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48526, encryptionId=6b3348526a0, topicName=帕金森病患)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73fe15977481, createdName=saikp, createdTime=Wed Aug 05 12:57:53 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610625, encodeId=ed481610625ad, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Aug 05 12:57:53 CST 2020, time=2020-08-05, status=1, ipAttribution=)]

相关资讯

麻辣锅底还是番茄锅底?选对食物帕金森病远离你!

有临床研究证明,尼古丁有望成为治疗帕金森症的有效药物。尼古丁作为一种生物碱,不仅仅存在于烟草之中,也存在于多种茄科植物的果实之中,例如番茄、辣椒、枸杞子等。

medRxiv:地中海饮食结合得舒饮食有助于延缓帕金森症发病,对女性尤为明显

导言:帕金森病(PD)是一种常见的神经系统变性疾病,我国65岁以上人群PD的患病率大约是1.7%。大部分帕金森病患者为散发病例,仅有不到10%的患者有家族史。近日,加拿大科学家发现,由地中海饮食(Me

Nature:Nature封面!付向东团队在体将胶质细胞转化为神经元

来自不同脑区的星形胶质细胞可以转化为不同的神经元亚型。

Brain:中南大学湘雅医院绘制中国大陆帕金森病基因突变图谱

最近,中南大学湘雅医院多位研究人员合作进行了一项研究,以确定中国大陆人群中家族性帕金森病和散发性早发性帕金森病(sEOPD)的突变谱及突变携带者的临床特征。

言语不清、肢体抖动 1 年,你的诊断是?

帕金森病(PD)和多系统萎缩(MSA)通常在疾病早期阶段很难鉴别,部分 MSA患者脑桥“十字征”或壳核外缘“裂隙征”不典型甚至缺如,那我们如何做到不误诊呢?

Behavioural Brain Research:利用自动纤维束分割技术研究帕金森氏病中的局部白质异常

白质(WM)结构的缺失与帕金森病(PD)的进展有关。目前的大多数方法都是基于感兴趣的皮层区域(ROIS)来识别关键的WM区域。然而,由于在灰色物质(GM)附近扩散各向异性低,这类ROI方法可能会受到挑

Baidu
map
Baidu
map
Baidu
map